Abstract:Therapeutic protein production in plants is an area of great potential for increasing and improving the production of proteins for the treatment or prevention of disease in humans and other animals. There are a number of key benefits of this technique for scientists and society, as well as regulatory challenges that need to be overcome by policymakers. Increased public understanding of the costs and benefits of therapeutic protein production in plants will be instrumental in increasing the acceptance, and thus the medical and veterinary impact, of this approach. Therapeutic recombinant proteins are a powerful tool for combating many diseases which have previously been hard to treat. The most utilized expression systems are Chinese Hamster Ovary cells and Escherichia coli, but all available expression systems have strengths and weaknesses regarding development time, cost, protein size, yield, growth conditions, posttranslational modifications and regulatory approval. The plant industry is well established and growing and harvesting crops is easy and affordable using current infrastructure. Growth conditions are generally simple: sunlight, water, and the addition of cheap, available fertilizers. There are multiple options for plant expression systems, including species, genetic constructs and protein targeting, each best suited to a particular type of therapeutic protein production. Transient expression systems provide a mechanism to rapidly transfect plants and produce therapeutic protein in a matter of weeks, rather than the months it can take for many competing expression systems, while proteins targeted to cereal seeds can be harvested, stored and potentially purified much more easily than in competing systems. Current challenges for plant expression systems include a lack of regulatory approval, environmental containment concerns and nonhuman glycosylation, which may limit the scope of the type of therapeutic proteins that can be manufactured in plants. The specific strengths of plant expression systems could facilitate the production of certain therapeutic proteins quickly and cheaply in the near future. Therapeutic protein production in plants is an area of great potential for increasing and improving the production of proteins for the treatment or prevention of disease in humans and other animals. There are a number of key benefits of this technique for scientists and society, as well as regulatory challenges that need to be overcome by policymakers. Increased public understanding of the costs and benefits of therapeutic protein production in plants will be instrumental in increasing the acceptance, and thus the medical and veterinary impact, of this approach.

Stable Plastid Transformation for High-Level Recombinant Protein Expression: Promises and Challenges.

Maximizing the Production of Recombinant Proteins in Plants: from Transcription to Protein Stability

Chloroplast Genetic Engineering: Recent Advances and Future Perspectives

Advances on the Expressions of Foreign Proteins in Plants

Recent Advances in Recombinant Pharmaceutical Proteins and Vaccines Production in Chloroplasts

Optimising expression and extraction of recombinant proteins in plants

Production of biopharmaceuticals and vaccines in plants via the chloroplast genome

Green biofactories: recombinant protein production in plants

Plant Expression System Progress of Recombinant Proteins

Improving Protein Quantity and Quality-The Next Level of Plant Molecular Farming

Progress in Chloroplast Transformation in Plants

Progress Of Transgenic Plant As Bioreactor For Pharmaceutical Proteins

Therapeutic recombinant protein production in plants: Challenges and opportunities

Stable Nuclear Transformation of the Industrial Alga Chlorella Pyrenoidosa

Review of Recombinant Therapeutic Protein Expression in Transgenic Plants

Towards green biomanufacturing of high-value recombinant proteins using promising cell factory: Chlamydomonas reinhardtii chloroplast

Plant-based expression platforms to produce high-value metabolites and proteins

Construction of Novel Chloroplast Expression Vector and Development of an Efficient Transformation System for the Diatom Phaeodactylum tricornutum

Research Progress, Bottlenecks and Strategies in the Plant Bioreactor

Plant-based biopharmaceutical engineering

Chloroplast-Derived Vaccine Antigens and Biopharmaceuticals: Expression, Folding, Assembly and Functionality